Any minimal selling of EPIC goes straight into Elites coffer for milestone payments and R&D for their BILLION dollar ART?ADT opiods. Its been this way since we were at $0.03 It was in the plan from the beginning. Remember we will have at least ONE ART Opiod n the FDA's desk this year. THey may surprise us with 2 or more.
Elite will cx the opioid pain sector as we know it. Take advantage of the times. GL
News 
Market Data 
Discover 
